{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T18:04:14Z","timestamp":1770919454760,"version":"3.50.1"},"reference-count":56,"publisher":"Begell House","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Immunol"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>&lt;b&gt;Background: &lt;\/b&gt;Sarcoidosis is a complex inflammatory disease of unknown etiology affecting mostly the lungs and poses a significant diagnostic challenge, particularly in regions where tuberculosis (TB) is endemic. The diagnostic complexity intensifies due to shared clinical and radiological features between sarcoidosis and TB, as well as similarities with idiopathic pulmonary fibrosis (IPF) in cases that progress to pulmonary fibrosis. Accurately distinguishing between these diseases is critical for timely and effective patient management.\n&lt;b&gt;Objective:&lt;\/b&gt; This study breaks new ground by evaluating the diagnostic power of the bronchoalveolar lavage (BAL) CD4\/ CD8 ratio, along with key activation and memory markers to differentiate sarcoidosis from TB, IPF, and other-interstitial lung diseases (ILDs).\n&lt;b&gt;Methods:&lt;\/b&gt; A cohort of 68 patients with ILDs, including sarcoidosis (&lt;i&gt;n&lt;\/i&gt; &amp;#61; 37), TB (&lt;i&gt;n&lt;\/i&gt; &amp;#61; 19), IPF (&lt;i&gt;n&lt;\/i&gt; &amp;#61; 6), and Other-ILDs (&lt;i&gt;n&lt;\/i&gt; &amp;#61;\n6) were assessed. The CD4\/CD8 ratio and a panel of activation and memory markers were analyzed through flow cytometry.\n &lt;b&gt;Results: &lt;\/b&gt;Sarcoidosis exhibited a significantly higher CD4\/CD8 ratio compared to those with TB, IPF, and Other-ILDs. An optimal cutoff value of 3.7 for the CD4\/CD8 ratio in sarcoidosis with an area under the ROC curve (AUC) of 0.7&amp;#37;, had a specificity of 96.8&amp;#37;, and a sensitivity of 43.2&amp;#37;. In addition, a significant difference was detected in CD38, CD45RA, CD45RO, and CD62L expression.\n&lt;b&gt;Conclusion:&lt;\/b&gt; Combining the CD4\/CD8 ratio (&amp;#62; 3.7) with the expression of CD38, CD62L, and memory markers is a promising new tool for the differential diagnosis of sarcoidosis.\n<\/p>","DOI":"10.1615\/critrevimmunol.2025056518","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T21:41:31Z","timestamp":1736890891000},"page":"77-89","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic Power of the CD4&amp;#43;\/CD8&amp;#43; Ratio and the Expression of Activation and Memory Markers in Differentiating Sarcoidosis from Tuberculosis, Idiopathic Pulmonary Fibrosis, and Other Interstitial Lung Diseases"],"prefix":"10.1615","volume":"45","author":[{"given":"Sara","family":"El Fakihi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aicha","family":"El Allam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hicham","family":"Tahoune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaimae","family":"Kadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azeddine","family":"Ibrahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamal-Eddine","family":"Bourkadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fouad","family":"Seghrouchni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"613","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Thomas KW, Hunninghake GW. Sarcoidosis. Am Med Assoc. 2003;289(24):3300-3. doi: 10.1001\/jama.289.24. 3300.","DOI":"10.1001\/jama.289.24.3300"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee. Am J Respir Crit Care Med. 1999;160(2):736-55. doi: 10.1164\/ajrccm.160.2.ats4-99.","DOI":"10.1164\/ajrccm.160.2.ats4-99"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Song Z, Marzilli L, Greenlee BM, Chen ES, Silver RF, Askin FB, Teirstein AS, Zhang Y, Cotter RJ, Moller DR. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med. 2005;201(5):755-67. doi: 10.1084\/jem.20040429.","DOI":"10.1084\/jem.20040429"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Agrawal R, Kee AR, Ang L, Tun Hang Y, Gupta V, Kon OM, Mitchell D, Zierhut M, Pavesio C. Tuberculosis or sarcoidosis: Opposite ends of the same disease spectrum? Tuberculosis. 2016;98:21-6. doi: 10.1016\/j. tube.2016.01.003.","DOI":"10.1016\/j.tube.2016.01.003"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Mortaz E, Masjedi MR, Abedini A, Matroodi S, Kiani A, Soroush D, Adcock IM. Common features of tuberculosis and sarcoidosis. Int J Mycobacteriol. 2016;5(1 Suppl): S240-S241. doi: 10.1016\/j.ijmyco.2016.09.031.","DOI":"10.1016\/j.ijmyco.2016.09.031"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Morgenthau AS. Combined sarcoidosis and idiopathic pulmonary fibrosis (CSIPF): Genuine disease entity, obscure clinical phenotype or diagnostic red herring? Respir Med. 2018;144S:S3-S4. doi: 10.1016\/j.rmed.2018.10.005.","DOI":"10.1016\/j.rmed.2018.10.005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Meyer KC, Raghu G. Bronchoalveolar lavage for the evaluation of interstitial lung disease: Is it clinically useful? Eur Respir J. 2011;38(4):761-9. doi: 10.1183\/09031936.00069509.","DOI":"10.1183\/09031936.00069509"},{"key":"8","unstructured":"Vijayan VK. Role of bronchoalveolar lavage in the diagnosis and immunological evaluation of patients with pulmonary tuberculosis. Indian J Tuberc. 2000;47(2):73-8."},{"key":"9","doi-asserted-by":"crossref","unstructured":"Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. Br Med J. 1961;2(5261):1165-72. doi: 10.1136\/bmj.2.5261.1165.","DOI":"10.1136\/bmj.2.5261.1165"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Harbeck R. Immunophenotyping of bronchoalveolar lavage lymphocytes. Clin Diagn Lab Immunol. 1998;5(3):271-7. doi: 10.1128\/cdli.5.3.271-277.1998.","DOI":"10.1128\/CDLI.5.3.271-277.1998"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Costabel U, Guzman J. Bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Med. 2001;7(5):255-61. doi: 10.1097\/00063198-200109000-00002.","DOI":"10.1097\/00063198-200109000-00002"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Tondell A, Ro AD, Asberg A, Borset M, Moen T, Sue-Chu M. Activated CD8+ T cells and NKT cells in BAL fluid improve diagnostic accuracy in sarcoidosis. Lung. 2014;192(1):133-40. doi: 10.1007\/s00408-013-9527-8.","DOI":"10.1007\/s00408-013-9527-8"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Nureki S ichi, Miyazaki E, Ando M, Ueno T, Fukami T, Kumamoto T, Sugisaki K, Tsuda T. Circulating levels of both Th1 and Th2 chemokines are elevated in patients with sarcoidosis. Respir Med. 2008;102(2):239-47. doi: 10.1016\/j.rmed.2007.09.006.","DOI":"10.1016\/j.rmed.2007.09.006"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Drent M, Mansour K, Linssen C. Bronchoalveolar lavage in sarcoidosis. Semin Respir Crit Care Med. 2007;28(5):486-95. doi: 10.1055\/s-2007-991521.","DOI":"10.1055\/s-2007-991521"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Suzuki E, Tsukada H, Ishida T, Ishizuka O, Hasegawa T, Gejyo F. Correlation between the numbers of gammadelta T cells and CD4+ HLA-DR+ T cells in broncho-alveolar lavage fluid from patients with diffuse lung disease, Tohoku J Exp Med. Published online 2002:196(4):231-40. doi: 10.1620\/tjem.196.231.","DOI":"10.1620\/tjem.196.231"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Papiris SA, Kollintza A, Karatza M, Manali ED, Sotiropoulou C, Milic-Emili J, Roussos C, Daniil Z. CD8+T lymphocytes in bronchoalveolar lavage in idiopathic pulmonary fibrosis. J Inflamm. 2007;4(14):1-7. doi: 10.1186\/1476-9255-4-14.","DOI":"10.1186\/1476-9255-4-14"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Daniil Z, Kitsanta P, Kapotsis G, Mathioudaki M, Kollintza A, Karatza M, Milic-Emili J, Roussos C, Papiris SA. CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis. Respir Res. 2005;6(1):2-9. doi: 10.1186\/1465-9921-6-81.","DOI":"10.1186\/1465-9921-6-81"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Deng L, Huang T, Zhang L. T cells in idiopathic pulmonary fibrosis: Crucial but controversial. Cell Death Discov. 2023;9(1). doi: 10.1038\/s41420-023-01344-x.","DOI":"10.1038\/s41420-023-01344-x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Greco S, Marruchella A, Massari M, Saltini C. Predictive value of BAL cellular analysis in differentiating pulmonary tuberculosis and sarcoidosis. Eur Respir J. 2005;26(2):360-1. doi: 10.1183\/09031936.05.00050405.","DOI":"10.1183\/09031936.05.00042905"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Hoheisel GB, Tabak L, Teschler H, Erkan F, Kroegel C, Costabel U. Bronchoalveolar lavage cytology and immunocytology in pulmonary tuberculosis. Am J Respir Crit Care Med. 1994;149(2 Pt 1):460-3. doi: 10.1164\/ajrccm.149.2.8306046.","DOI":"10.1164\/ajrccm.149.2.8306046"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Lin PL, Flynn JL. CD8 T cells and Mycobacterium tuberculosis infection. Semin Immunopathol. 2015;37(3):239-49. doi: 10.1007\/s00281-015-0490-8.","DOI":"10.1007\/s00281-015-0490-8"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Danila E, Norkuniene J, Jurgauskiene L, Malickaite R. Diagnostic role of BAL fluid CD4\/CD8 ratio in different radiographic and clinical forms of pulmonary sarcoidosis. Clin Respir J. 2009;3(4):214-21. doi: 10.1111\/j.1752-699X.2008.00126.x.","DOI":"10.1111\/j.1752-699X.2008.00126.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Winterbauer RH, Lammert J, Selland M, Wu R, Corley D, Springmeyer SC. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest. 1993;104(2):352-61. doi: 10.1378\/chest.104.2.352.","DOI":"10.1378\/chest.104.2.352"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Lee W, Chung WS, Hong KS, Huh J. Clinical usefulness of bronchoalveolar lavage cellular analysis and lymphocyte subsets in diffuse interstitial lung diseases. Ann Lab Med. 2015;35(2):220-5. doi: 10.3343\/alm.2015.35.2.220.","DOI":"10.3343\/alm.2015.35.2.220"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Bretagne L, Diatta ID, Faouzi M, Nobile A, Bongiovanni M, Nicod LP, Lazor R. Diagnostic value of the CD103+CD4+\/CD4+ ratio to differentiate sarcoidosis from other causes of lymphocytic alveolitis. Respiration. 2016;91(6):486-96. doi: 10.1159\/000446606.","DOI":"10.1159\/000446606"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Kantrow SP, Meyer KC, Kidd P, Raghu G. The CD4\/CD8 ratio in BAL fluid is highly variable in sarcoidosis. Eur Respir J. 1997;10(12):2716-21. doi: 10.1183\/09031936.97.10122716.","DOI":"10.1183\/09031936.97.10122716"},{"key":"27","unstructured":"Hoser G, Kawiak J, Domagala-Kulawik J, Kopinski P, Droszcz W. Flow cytometric evaluation of lymphocyte subpopulations in BALF of healthy smokers and nonsmokers. Folia Histochem Cytobiol. 1999;37(1):25-30."},{"key":"28","doi-asserted-by":"crossref","unstructured":"Korosec P, Rijavec M, Silar M, Kern I, Kosnik M, Osolnik K. Deficiency of pulmonary Valpha24 Vbeta11 natural killer T cells in corticosteroid-naive sarcoidosis patients. Respir Med. 2010;104(4):571-7. doi: 10.1016\/j.rmed.2009.11.008.","DOI":"10.1016\/j.rmed.2009.11.008"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Fireman E, Boikaner T, Priel IE. Combined CD4\/CD8 ratio in induced sputum and pulmonary function testing for non-invasive identification of sarcoidosis. Transl Res. 2006;148(2):87-95. doi: 10.1016\/j.trsl.2006.03.005.","DOI":"10.1016\/j.trsl.2006.03.005"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, Du Bois RM, Drent M, Haslam PL, Kim DS, Nagai S, Rottoli P, Saltini C, Selman M, Strange C, Wood B. American Thoracic Society Committee on BAL in Interstitial Lung Disease. An official American Thoracic Society clinical practice guideline: The clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185(9):1004-14. doi: 10.1164\/rccm.201202-0320ST.","DOI":"10.1164\/rccm.201202-0320ST"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Danila E, Jurgauskiene L, Norkuniene J, Malickaite R. BAL fluid cells in newly diagnosed pulmonary sarcoidosis with different clinical activity. Ups J Med Sci. 2009;114(1):26-31. doi: 10.1080\/03009730802579729.","DOI":"10.1080\/03009730802579729"},{"key":"32","unstructured":"He QY, Kitamura S, Ishii Y. Measurement of T cell subsets in bronchoalveolar lavage fluid for diagnosis of pulmonary sarcoidosis. Zhonghua Yi Xue Za Zhi. 1994;74(2):87-9, 126-7 (in Chinese)."},{"key":"33","doi-asserted-by":"crossref","unstructured":"Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: A disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med. 1981;305(8):429-34. doi: 10.1056\/NEJM198108203050804.","DOI":"10.1056\/NEJM198108203050804"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Pinkston P, Bitterman PB, Crystal RG. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med. 1983;308(14):793-800. doi: 10.1056\/NEJM198304073081401.","DOI":"10.1056\/NEJM198304073081401"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Saltini C, Spurzem JR, Lee JJ, Pinkston P, Crystal RG. Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subset. J Clin Invest. 1986;77(6):1962-70. doi: 10.1172\/JCI112525.","DOI":"10.1172\/JCI112525"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Aleksoniene R, Besusparis J, Gruslys V, Jurgauskiene L, Laurinaviciene A, Laurinavicius A, Malickaite R, Norkuniene J, Zablockis R, Zurauskas E, Danila E. CD31+, CD38+, CD44+, and CD103+ lymphocytes in peripheral blood, bronchoalveolar lavage fluid and lung biopsy tissue in sarcoid patients and controls. J Thorac Dis. 2021;13(4):2300-18. doi: 10.21037\/jtd-20-2396.","DOI":"10.21037\/jtd-20-2396"},{"key":"37","unstructured":"Costabel U, Bross KJ, Ruhle KH, Lohr GW, Matthys H. Ia-like antigens on T-cells and their subpopulations in pulmonary sarcoidosis and in hypersensitivity pneumonitis. Analysis of bronchoalveolar and blood lymphocytes. Am Rev Respir Dis. 1985;131(3):337-42."},{"key":"38","doi-asserted-by":"crossref","unstructured":"Groen H, Hamstra M, Aalbers R, van der Mark TW, Koeter GH, Postma DS. Clinical evaluation of lymphocyte sub-populations and oxygen radical production in sarcoidosis and idiopathic pulmonary fibrosis. Respir Med. 1994;88(1):55-64. doi: 10.1016\/0954-6111(94)90175-9.","DOI":"10.1016\/0954-6111(94)90175-9"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Jurgauskiene LG, Malickaite R, Aleksoniene R, Simanaviciene S, Danila E. Influence of smoking on multifunctional membrane surface glycoprotein expression on the surface of T lymphocytes in BAL fluid from patients with pulmonary sarcoidosis. Eur Respir J. 2016;48(60 Suppl):PA906. doi: 10.1183\/13993003.congress-2016.PA906.","DOI":"10.1183\/13993003.congress-2016.PA906"},{"key":"40","unstructured":"Moller DR. Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc Diffus Lung Dis. 1999;16(1):24-31."},{"key":"41","doi-asserted-by":"crossref","unstructured":"Agostini C, Adami F, Semenzato G. New pathogenetic insights into the sarcoid granuloma. Curr Opin Rheumatol. 2000;12(1):71-6. doi: 10.1097\/00002281-200001000-00012.","DOI":"10.1097\/00002281-200001000-00012"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol. 2007;37(1):129-38. doi: 10.1002\/eji.200636435.","DOI":"10.1002\/eji.200636435"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Grutters JC, Fellrath JM, Mulder L, Janssen R, Van Den Bosch JM, Van Velzen-Blad H. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: A clinical evaluation. Chest. 2003;124(1):186-95. doi: 10.1378\/chest.124.1.186.","DOI":"10.1378\/chest.124.1.186"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Prasse A, Georges CG, Biller H, Hamm H, Matthys H, Luttmann W, Virchow JC. Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells. Clin Exp Immunol. 2000;122(2):241-8. doi: 10.1046\/j.1365-2249.2000.01365.x.","DOI":"10.1046\/j.1365-2249.2000.01365.x"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Heron M, Claessen AME, Grutters JC, Van Den Bosch JMM. T cell activation profiles in different granulomatous interstitial lung diseases-A role for CD8+CD28null cells? Clin Exp Immunol. 2010;160(2):256-65. doi: 10.1111\/j.1365-2249.2009.04076.x.","DOI":"10.1111\/j.1365-2249.2009.04076.x"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Li L, Qiao D, Fu X, Lao S, Zhang X, Wu C. Identification of M.tuberculosis-specific th1 cells expressing CD69 generated in vivo in pleural fluid cells from patients with tuberculous pleurisy. PLoS One. 2011;6(8). doi: 10.1371\/journal.pone.0023700.","DOI":"10.1371\/journal.pone.0023700"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Mollers M, Aries SP, Dromann D, Mascher B, Braun J, Dalhoff K. Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis. Thorax. 2001;56(6):487-93. doi: 10.1136\/thorax.56.6.487.","DOI":"10.1136\/thorax.56.6.487"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Dominique S, Bouchonnet F, Smiejan JM, Hance AJ. Expression of surface antigens distinguishing 'naive' and previously activated lymphocytes in bronchoalveolar lavage fluid. Thorax. 1990;45(5):391-6. doi: 10.1136\/thx.45.5.391.","DOI":"10.1136\/thx.45.5.391"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Fazel SB, Howie SEM, Krajewski AS, Lamb D. Increased CD45RO expression on T lymphocytes in mediastinal lymph node and pulmonary lesions of patients with pulmonary sarcoidosis. Clin Exp Immunol. 1994;95(3):509-13. doi: 10.1111\/j.1365-2249.1994.tb07027.x.","DOI":"10.1111\/j.1365-2249.1994.tb07027.x"},{"key":"50","doi-asserted-by":"crossref","unstructured":"Westermann J, Bode U. Distribution of activated T cells migrating through the body: A matter of life and death. Immunol Today. 1999;20(7):302-6. doi: 10.1016\/s0167-5699(99)01474-7.","DOI":"10.1016\/S0167-5699(99)01474-7"},{"key":"51","doi-asserted-by":"crossref","unstructured":"Berard M, Tough DF. Qualitative differences between naive and memory T cells. Immunology. 2002;106(2):127-38. doi: 10.1046\/j.1365-2567.2002.01447.x.","DOI":"10.1046\/j.1365-2567.2002.01447.x"},{"key":"52","doi-asserted-by":"crossref","unstructured":"Urdaneta E, Feo-Figarella E, Montalvo C, Talamo C, Castillo Y, Carrasco D, Rivera H, Blanca I, Machado I, Echeverria De Perez G, De Sanctis JB, Bianco NE. Characterization of local memory cells in stage-classified pulmonary tuberculosis: Preliminary observations. Scand J Immunol. 1998;47(5):496-501. doi: 10.1046\/j.1365-3083.1998.00325.x.","DOI":"10.1046\/j.1365-3083.1998.00325.x"},{"key":"53","doi-asserted-by":"crossref","unstructured":"Adams DH, Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet. 1994;343(8901):831-6. doi: 10.1016\/S0140-6736(94)92029-X.","DOI":"10.1016\/S0140-6736(94)92029-X"},{"key":"54","doi-asserted-by":"crossref","unstructured":"Xu J, Grewal IS, Geba GP, Flavell RA. Impaired primary T cell responses in L-selectin-deficient mice. J Exp Med. 1996;183(2):589-98. doi: 10.1084\/jem.183.2.589.","DOI":"10.1084\/jem.183.2.589"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Georas SN, Liu MC, Newman W, Beall LD, Stealey BA, Bochner BS. Altered adhesion molecule expression and endothelial cell activation accompany the recruitment of human granulocytes to the lung after segmental antigen challenge. Am J Respir Cell Mol Biol. 1992;7(3):261-9. doi: 10.1165\/ajrcmb\/7.3.261.","DOI":"10.1165\/ajrcmb\/7.3.261"},{"key":"56","doi-asserted-by":"crossref","unstructured":"Kaseda M, Kadota JI, Mukae H, Kawamoto S, Shukuwa T, Iwashita T, Matsubara Y, Ishimatsu Y, Yoshinaga M, Abe K, Kohno S. Possible role of L-selectin in T lymphocyte alveolitis in patients with active pulmonary sarcoidosis. Clin Exp Immunol. 2000;121(1):146-50. doi: 10.1046\/j.1365-2249.2000.01267.x.","DOI":"10.1046\/j.1365-2249.2000.01267.x"}],"container-title":["Critical Reviews in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/2fb8b43e1e9e52ad\/CRI-56518.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T07:55:59Z","timestamp":1740470159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/2ff21abf44b19838,444f93487bf4d1c4,2fb8b43e1e9e52ad.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/critrevimmunol.2025056518","relation":{},"ISSN":["1040-8401"],"issn-type":[{"value":"1040-8401","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}